These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4007415)

  • 1. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.
    Yokosuka O; Omata M; Imazeki F; Hirota K; Mori J; Uchiumi K; Ito Y; Okuda K
    Gastroenterology; 1985 Aug; 89(2):246-51. PubMed ID: 4007415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M; Uchiumi K
    J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term prednisolone followed by recombinant human alpha-interferon alone or combined with adenine-arabinoside in chronic hepatitis B. A prospective and randomized trial.
    Brissot P; Jacquelinet C; Jouanolle H; David V; Guyader D; Guéguen M; Blayau M; Lescoat G; Messner M; Deugnier Y
    J Hepatol; 1991 Mar; 12(2):181-9. PubMed ID: 2050997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.
    Takano S; Omata M; Yokosuka O; Imazeki F; Ohto M
    Dig Dis Sci; 1992 Nov; 37(11):1633-43. PubMed ID: 1425062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
    Scullard GH; Andres LL; Greenberg HB; Smith JL; Sawhney VK; Neal EA; Mahal AS; Popper H; Merigan TC; Robinson WS; Gregory PB
    Hepatology; 1981; 1(3):228-32. PubMed ID: 6169615
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
    Hoofnagle JH; Davis GL; Hanson RG; Pappas SC; Peters MG; Avigan MI; Waggoner JG; Howard R; Jones EA; Straus SE
    J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
    Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis.
    Lee SU; Choi KH; Ha BJ; Suh SY; Han BH; Ku JY; Park BC
    Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
    Liaw YF; Lin DY; Chen TJ; Chu CM; Sheen IS
    Infection; 1984; 12(4):248-50. PubMed ID: 6490167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
    Scullard GH; Pollard RB; Smith JL; Sacks SL; Gregory PB; Robinson WS; Merigan TC
    J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.
    Hoofnagle JH; Davis GL; Pappas SC; Hanson RG; Peters M; Avigan MI; Waggoner JG; Jones EA; Seeff LB
    Ann Intern Med; 1986 Jan; 104(1):12-7. PubMed ID: 3940480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B.
    Kumada H; Ikeda K; Yoshida A; Seto S; Tsukada T; Kojima M; Suzuki H; Mayumi M
    Jpn J Med; 1987 May; 26(2):217-22. PubMed ID: 3626161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
    Loeschke K; Abb J; Farack UM; Wiebecke B
    Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection.
    Watanabe S; Saito S; Yoshikawa A; Shibayama T; Kamimura T; Suzuki S; Ischida F
    Hepatogastroenterology; 1982 Jun; 29(3):102-5. PubMed ID: 7106692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.
    Itoh S; Matsuo S; Oda T; Marutani K; Sasaki K
    Dig Dis Sci; 1990 Sep; 35(9):1110-4. PubMed ID: 2390925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
    Marcellin P; Pouteau M; Loriot MA; Boyer N; Degos F; Calès P; Bettan L; Bacq Y; Coppére H; Grange JD
    Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.
    Rakela J; Redeker AG; Weliky B
    Gastroenterology; 1983 May; 84(5 Pt 1):956-60. PubMed ID: 6832570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.